US7998693B2ExpiredUtilityA1
Gene specific to cancer and diagnosis kit using the same
Est. expiryJan 5, 2025(expired)· nominal 20-yr term from priority
G01N 33/57595C12Q 1/6886C12Q 2600/158C07K 14/47
43
PatentIndex Score
0
Cited by
11
References
1
Claims
Abstract
The present invention provides a new additional identification of a gene related to cancer expression and a diagnostic kit using the same.
Claims
exact text as granted — not AI-modified1. A method for detecting rectal cancer or colon cancer, comprising the steps of: measuring an expression level of a protein consisting of an amino-acid sequence as in SEQ ID NO: 2 for each of two collected cells, wherein one of said two collected cells is a cell from a non-cancer tissue and the other of said two collected cells is a cell from a tissue suspected to be a cancer tissue, and wherein said measuring is performed comprising using western blot analysis and using an antibody against the protein consisting of the amino-acid sequence as in SEQ ID NO: 2; calculating a ratio between the measured expression levels; and determining the other cell is a rectal cancer or colon cancer cell if the ratio between the measured expression levels is equal to or greater than 1.7.
Join the waitlist — get patent alerts
Track US7998693B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.